To assess the usefulness of new EBUS-TBNA needle.

To assess the usefulness of new EBUS-TBNA needle. - To assess the usefulness of new EBUS-TBNA needle.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000031291

Enrollment

Registered

2018-02-20

Start date

2018-02-20

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non-small cell lung cancer with advanced stage

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Patients with enlarged mediastinal and/or hilar lesions 10 mm or greater in short-axis diameter on CT or FDG uptaken 2.5 or higher in PET/CT imaging requiring diagnostic EBUS-TBNA 2. 20 years old and above 3. Informed consent

Exclusion criteria

Exclusion criteria: 1.Patients requiring EBUS-TBNA for N-stage in patients with lung cancer 2.Serious concomitant medical illness

Design outcomes

Primary

Measure	Time frame
Yields of adequate tissue specimen sampling	—

Countries

Japan

Contacts

Public ContactToshiyuki Nakai

National Cancer Center Hospital Department of Endoscopy, Respiratory Endoscopy Division

tnakai@ncc.go.jp03-3542-2511

Outcome results